Free Trial

Climb Bio (CLYM) Earnings Date, Estimates & Call Transcripts

Climb Bio logo
$2.38 +0.19 (+8.68%)
As of 08/22/2025 04:00 PM Eastern

Climb Bio Earnings Summary

Climb Bio announced Q2 2025 earnings on August 12, 2025, reporting an EPS of -$0.13, which beat the consensus estimate of -$0.19 by $0.06. With a trailing EPS of -$0.70, Climb Bio's earnings are expected to grow next year, from ($1.57) to ($0.66) per share.

Upcoming Q3
Earnings Date
Nov. 11Before Market OpensEstimated
Consensus EPS
(Aug. 12)
-$0.19
Actual EPS
(Aug. 12)
-$0.13 Beat By $0.06

Q2 2025 Earnings Resources

CLYM Upcoming Earnings

Climb Bio's next earnings date is estimated for Tuesday, November 11, 2025, based on past reporting schedules.

Get Climb Bio Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Climb Bio and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

CLYM Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Climb Bio Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20251-$0.15-$0.15-$0.15
Q2 20251-$0.18-$0.18-$0.18
Q3 20251-$0.16-$0.16-$0.16
Q4 20251-$0.18-$0.18-$0.18

Climb Bio Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/11/2025
(Estimated)
--------
8/12/2025Q2 2025-$0.19-$0.13+$0.06-$0.13--
5/14/2025Q1 2025-$0.15-$0.31 -$0.16-$0.31--
3/25/2025Q4 2024-$0.15-$0.13+$0.02-$0.13--
11/12/2024---$0.13--$0.13--

Climb Bio Earnings - Frequently Asked Questions

Climb Bio has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 11th, 2025 based off last year's report dates. Learn more on CLYM's earnings history.

In the previous quarter, Climb Bio (NASDAQ:CLYM) reported ($0.13) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.19) by $0.06. Learn more on analysts' earnings estimate vs. CLYM's actual earnings.

Climb Bio (NASDAQ:CLYM) has a recorded net income of -$73.90 million. CLYM has generated -$0.70 earnings per share over the last four quarters.

Climb Bio's earnings are expected to grow from ($1.57) per share to ($0.66) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:CLYM) was last updated on 8/23/2025 by MarketBeat.com Staff
From Our Partners